These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37718535)

  • 1. Interest of nail clipping tests to discriminate a tail end of a doping regimen from a contamination in case of challenging an adverse analytical finding: Case reports involving ostarine.
    Kintz P; Gheddar L; Ameline A
    Drug Test Anal; 2024 May; 16(5):515-517. PubMed ID: 37718535
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of S22 (ostarine) in human nails and hair using LC-HRMS. Application to two authentic cases.
    Kintz P; Gheddar L; Ameline A; Raul JS
    Drug Test Anal; 2020 Oct; 12(10):1508-1513. PubMed ID: 32688441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
    Alvarez JC; Etting I; Larabi IA
    Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of ostarine excretion in oral fluid after a single controlled oral administration.
    Kintz P; Gheddar L; Garnier D
    Clin Chim Acta; 2024 Apr; 557():117879. PubMed ID: 38499138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authorities.
    Kintz P; Gheddar L
    Clin Chim Acta; 2024 Jun; 559():119688. PubMed ID: 38670521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion.
    Walpurgis K; Rubio A; Wagener F; Krug O; Knoop A; Görgens C; Guddat S; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1570-1580. PubMed ID: 32959982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for anabolic steroids in human nail clippings.
    Kintz P; Gheddar L; Raul JS
    J Forensic Sci; 2021 Jul; 66(4):1577-1582. PubMed ID: 33885144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of nails as an alternative matrix for the long-term detection of previous drug intake: validation of sensitive UHPLC-MS/MS methods for the quantification of 76 substances and comparison of analytical results for drugs in nail and hair samples.
    Krumbiegel F; Hastedt M; Westendorf L; Niebel A; Methling M; Parr MK; Tsokos M
    Forensic Sci Med Pathol; 2016 Dec; 12(4):416-434. PubMed ID: 27515931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sports drug testing and the athletes' exposome.
    Thevis M; Kuuranne T; Fedoruk M; Geyer H
    Drug Test Anal; 2021 Nov; 13(11-12):1814-1821. PubMed ID: 34694748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
    Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tainted toothpaste - Analytical investigation into an unusual adverse finding.
    Schänzer W; Geyer H; Thevis M
    Drug Test Anal; 2020 May; 12(5):570-572. PubMed ID: 31910320
    [No Abstract]   [Full Text] [Related]  

  • 13. Doping in sport: misuse, analytical tests, and legal aspects.
    Cowan DA; Kicman AT
    Clin Chem; 1997 Jul; 43(7):1110-3. PubMed ID: 9216446
    [No Abstract]   [Full Text] [Related]  

  • 14. Doping control in sports medicine.
    Segura J
    Ther Drug Monit; 1996 Aug; 18(4):471-6. PubMed ID: 8857571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Are the Prerequisites to Account for "No Fault" in Doping Control after an Adverse Analytical Finding Possibly due to Drug Contamination? Perspective from a Hair Testing Analyst.
    Kintz P
    J Anal Toxicol; 2021 Feb; 45(2):e3-e5. PubMed ID: 33150948
    [No Abstract]   [Full Text] [Related]  

  • 16. Nail Analysis for Drugs: A Role in Workplace Testing?
    Hill VA; Stowe GN; Paulsen RB; Schaffer M
    J Anal Toxicol; 2018 Jul; 42(6):425-436. PubMed ID: 29554333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical challenges in sports drug testing.
    Thevis M; Krug O; Geyer H; Walpurgis K; Baume N; Thomas A
    Anal Bioanal Chem; 2018 Mar; 410(9):2275-2281. PubMed ID: 29445832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of undeclared doping substances in nutritional supplements in the context of follow-up investigations concerning adverse analytical findings.
    Mareck U; Geyer H; Schertel T; Petring S; Krug O; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1911-1914. PubMed ID: 34476910
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.